230 related articles for article (PubMed ID: 19556941)
1. Lacosamide for epilepsy.
Med Lett Drugs Ther; 2009 Jun; 51(1315):50-2. PubMed ID: 19556941
[No Abstract] [Full Text] [Related]
2. Lacosamide: new drug. Refractory partial epilepsy: optimise existing combinations.
Prescrire Int; 2009 Oct; 18(103):196. PubMed ID: 19882781
[No Abstract] [Full Text] [Related]
3. New epilepsy treatment receives FDA approval.
Lavine G
Am J Health Syst Pharm; 2008 Dec; 65(24):2310. PubMed ID: 19052267
[No Abstract] [Full Text] [Related]
4. Lacosamide.
Perucca E; Yasothan U; Clincke G; Kirkpatrick P
Nat Rev Drug Discov; 2008 Dec; 7(12):973-4. PubMed ID: 19043448
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials].
Mil'chakova LE; Gekht AB
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):39-43. PubMed ID: 20873472
[No Abstract] [Full Text] [Related]
6. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
[TBL] [Abstract][Full Text] [Related]
7. [Lacosamide--oral administration (Vimpat) ].
Duh D; Peeters S
J Pharm Belg; 2011 Mar; (1):25-6. PubMed ID: 21473129
[No Abstract] [Full Text] [Related]
8. The adjuvant treatment of partial seizures in epilepsy: focus on lacosamide. Foreword.
Ben-Menachem E
CNS Drugs; 2011 Dec; 25 Suppl 1():1-2. PubMed ID: 22141346
[No Abstract] [Full Text] [Related]
9. [The experience treatment of adjunctive lacosamide for patients with drug-resistance partial epilepsy].
Kissin MY; Bondarenko II
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):23-8. PubMed ID: 24107876
[TBL] [Abstract][Full Text] [Related]
10. Lacosamide for the treatment of epilepsy.
Krauss GL; Edwards HB; Lin B
Ann Med; 2012 Nov; 44(7):674-9. PubMed ID: 22380697
[TBL] [Abstract][Full Text] [Related]
11. Lacosamide and epilepsy.
Harris JA; Murphy JA
CNS Neurosci Ther; 2011 Dec; 17(6):678-82. PubMed ID: 20950330
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide as adjunctive therapy for partial-onset epileptic seizures: a review of the clinical and economic literature.
Simoens S
Curr Med Res Opin; 2011 Jul; 27(7):1329-38. PubMed ID: 21561394
[TBL] [Abstract][Full Text] [Related]
13. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy.
Scott LJ
Drugs; 2015 Dec; 75(18):2143-54. PubMed ID: 26607484
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
Tilz C; Resch R; Hofer T; Eggers C
Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
[TBL] [Abstract][Full Text] [Related]
15. Sinus node dysfunction: an adverse effect of lacosamide.
Chinnasami S; Rathore C; Duncan JS
Epilepsia; 2013 Jun; 54(6):e90-3. PubMed ID: 23360388
[TBL] [Abstract][Full Text] [Related]
16. [Lacosamide (vimpat). Prospects for clinical application].
Rudakova IG; Vlasov PN; Lipatova LV; Voronkova KV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):147-152. PubMed ID: 29053136
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide-induced valproic acid toxicity.
Jones GL; Popli GS; Silvia MT
Pediatr Neurol; 2013 Apr; 48(4):308-10. PubMed ID: 23498565
[TBL] [Abstract][Full Text] [Related]
18. Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures.
Rudd GD; Haverkamp W; Mason JW; Wenger T; Jay G; Hebert D; Doty P; Horstmann R
Acta Neurol Scand; 2015 Nov; 132(5):355-63. PubMed ID: 25933358
[TBL] [Abstract][Full Text] [Related]
19. [New anticonvulsants under evaluation].
Kreutzberg K
MMW Fortschr Med; 1999 Oct; 141(40):13-4. PubMed ID: 10897990
[No Abstract] [Full Text] [Related]
20. Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures.
Ben-Menachem E
Drugs Today (Barc); 2008 Jan; 44(1):35-40. PubMed ID: 18301802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
